Title:
Emergence of immune escape at dominant SARS-CoV-2 killer T-cell epitope
Authors:
Garry Dolton, Cristina Rius, Md Samiul Hasan, Barbara Szomolay, Enas Behiry, Thomas Whalley, Joel Southgate, The COVID-19 Genomics UK (COG-UK) consortium, Théo Morin, Katie Topley, Li Rong Tan, Anna Fuller, Aaron Wall, Philip J. R. Goulder, Brad Spiller, Lucy C. Jones, Thomas R. Connor & Andrew K. Sewell
Published:
medRxiv, 28 June 2021
[This article is a preprint and has not been certified by peer review.]
Abstract:
The adaptive immune system protects against infection via selection of specific antigen receptors on B-cells and T-cells. We studied the prevalent CD8 ‘killer’ T-cell response mounted against SARS-CoV-2 Spike269-277 epitope YLQPRTFLL via the most frequent Human Leukocyte Antigen (HLA) class I worldwide, HLA A*02. The widespread Spike P272L mutation has arisen in five different SARS-CoV-2 lineages to date and was common in the B.1.177 lineage associated with establishing the ‘second wave’ in Europe. The large CD8 T-cell response seen across a cohort of HLA A*02+ convalescent patients, comprising of over 120 different TCRs, failed to respond to the P272L variant suggesting that proline 272 dominates TCR contacts with this epitope. Additionally, sizable populations (0.01%-0.2%) of total CD8 T-cells from individuals vaccinated against SARS-CoV-2 stained with HLA A*02-YLQPRTFLL multimers but failed to bind to the P272L reagent. Viral escape at prevalent T-cell epitopes restricted by high frequency HLA may be particularly problematic when vaccine immunity is focussed on a single protein such as SARS-CoV-2 Spike and provides a strong argument for inclusion of multiple viral proteins in next generation vaccines and highlights the urgent need for monitoring T-cell escape in new SARS-CoV-2 variants.